Institutions / Sphera Funds Management Ltd. / Holdings
Back to Sphera Funds Management Ltd.

Sphera Funds Management Ltd.

All holdings · as of Dec 31, 2025

94 positions

CompanyClassValueShares% of portfolio
MEDIWOUND LTD—$4.25M230,3470.9%
ASTRIA THERAPEUTICS INC—$4.66M355,7251.0%
SOLAREDGE TECHNOLOGIES INC—$4.70M4,000,0001.0%
Tango Therapeutics, Inc.—$4.82M544,5631.0%
Kodiak Sciences Inc.KODCommon Stock$4.91M175,5001.0%
Forte Biosciences, Inc.—$5.07M185,8691.1%
NOVARTIS AG—$5.10M37,0001.1%
Merck & Co., Inc.—$5.12M48,6001.1%
Vor Biopharma Inc.—$5.37M410,4171.1%
ACADIA Pharmaceuticals Inc—$5.67M212,2021.2%
SOLAREDGE TECHNOLOGIES, INC.—$5.67M196,5361.2%
AbbVie Inc.—$5.77M25,2561.2%
Cytokinetics Inc—$5.83M91,7171.2%
NOVO-NORDISK A S—$5.89M115,6771.2%
Enphase Energy, Inc.—$5.98M186,5001.2%
GSK PLC—$5.98M122,0001.3%
Apellis Pharmaceuticals, Inc.—$6.30M250,9611.3%
SOLENO THERAPEUTICS, INC.—$6.31M136,3141.3%
Celldex Therapeutics, Inc.—$6.51M239,7641.4%
BIOCRYST PHARMACEUTICALS INC—$6.54M837,8891.4%
Annexon, Inc.—$6.61M1,316,2121.4%
Cybin Inc.—$6.75M825,5761.4%
Ultragenyx Pharmaceutical Inc.—$6.91M300,6231.4%
WAVE LIFE SCIENCES LTD—$6.94M408,1661.5%
Scholar Rock Holding Corp—$6.97M158,2651.5%
Savara IncSVRACommon Stock$7.10M1,178,1641.5%
JOHNSON & JOHNSON—$7.42M35,8311.5%
Trevi Therapeutics, Inc.—$7.49M598,5341.6%
Dyne Therapeutics, Inc.—$7.69M392,8941.6%
Oric Pharmaceuticals, Inc.—$8.22M1,004,3781.7%
BridgeBio Pharma, Inc.—$8.24M107,7461.7%
BioMarin Pharmaceutical Inc—$8.74M147,0001.8%
IMMATICS N.V—$9.04M861,1051.9%
AMICUS THERAPEUTICS INC—$9.38M658,3772.0%
ELI LILLY & Co—$9.72M9,0402.0%
SANOFI—$11.61M239,5152.4%
ASTRAZENECA PLC—$12.42M135,0602.6%
Cogent Biosciences, Inc.—$13.44M378,5002.8%
TOWER SEMICONDUCTOR LTD—$14.39M122,5133.0%
NOVA LTD—$15.71M47,8463.3%
Syndax Pharmaceuticals Inc—$16.02M762,5633.3%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$16.29M449,0033.4%
BIOGEN INC.—$16.67M94,7383.5%
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVAADR$35.07M1,123,5257.3%
← PrevPage 2 of 2Next →